We are talking about people who received the vaccine from AstraZeneca.
The European medicines regulator has received reports of 169 cases of a rare form of brain circulation disorder in people who received the AstraZeneca vaccine, a senior official said on Wednesday.
As of April 4, 169 cases of dura mater sinus thrombosis were reported for 34 million doses of the vaccine administered in the European Economic Area, said Sabine Strauss, chair of the Safety Committee of the European Medicines Agency (EMA).
Earlier, the agency announced that it had found a possible link between the vaccine and rare cases of thrombosis in vaccinated adults.
The agency stressed that the benefits of vaccination outweigh the risks.